Eye Cipro

Al-Tinez Visions Limited
9, Olowogbowo Str off Obokun Str by Coker Rd, Ilupeju, Lagos
Tel: 01-7418609, 08296588658, 0708900917

Brand Name

Eye Cipro


ALPA LABORATORIES LTD. 33/2, A.B. Road, Pigdamber - 453 446

Therapeutic Class

Antibacterial, Quinolones

Dosage Form, Composition & NAFDAC Registration Number (NRN)

Drops (NRN:A4-7925): Ciprofloxacin Hydrochloride BP Eq. to Ciprofloxacin: 0.3% w/v Benzalkonium Chloride BP(as preservative): 0.5% w/v Sterile aqueous vehicle q.s

Pack size: 10 mL vial.

eye cipro


Ciprofloxacin has in vitro activity against a wide range of gram- negative and gram-positive microorganisms. The bactericidal action of Ciprofloxacin results from interference with the enzyme DNA gyrase which is needed for the synthesis of bacterial DNA.


Ciprofloxacin which is a potent, broad spectrum, synthetic antibacterial agent belonging to the fluoroquinolone group.

It exerts its bactericidal effect by inhibiting DNA gyrase, an essential enzyme involved in DNA replication.

Ciprofloxacin eye drop is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below:

Corneal Ulcers:
Pseudomonas aeruginosa
Serratia marcescens
Staphylococcus aureus
Staphylococcus epidermis
Streptococcus pneumonias
Streptococcus (Viridans Group)

Haemophilus influenzas
Staphylococcus aureus
Staphylococcus epidermis
Streptococcus pneumoniae
*Efficacy for this organism was studied in fewer than 10 infections.


Hypersensitivity to quinolone group of antibacterials or any of the components of the formulation.



Specific drug interaction studies have not been conducted with ophthalmic Ciprofloxacin.

Safety in pregnant women has not been established.

It is not known whether topically applied Ciprofloxacin is secreted in breast milk. However, caution should be exercised when administering to a nursing mother.

Adverse Effects

The most frequently reported side effect was local burning or discomfort. In corneal ulcer studies was frequent administration of the drug, white crystalline precipitates were seen in approximately 57% of patients.

Additional events occurring in less than 1% of patients included corneal staining, keratopathy/keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, nausea and decreased vision.

Dosage & Administration

As directed by Physician.
Do not touch the dropper tip to any surface or wash the dropper since this may contains the solution.

A topical overdose may be flushed from the eye/s with tap water.

Storage/Handling Recommendations

Store in a cool and dark place.

SHELF LIFE: 36 Months


Review Date

2016-05-10 12:06:25